Hedgehog signaling pathway and its targets for treatment in basal cell carcinoma

References

• American Cancer SocietyCancer Facts and Figures 2012Atlanta, GAAmerican Cancer Society2012 Available from: http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/document/acspc-031941.pdfAccessed November 5, 2012
   Google Scholar
• KimRHArmstrongAWNonmelanoma skin cancerDermatol Clin201230112513922117874
   PubMed Web of Science ®Google Scholar
• RubinAIChenEHRatnerDBasal-cell carcinomaN Engl J Med2005353212262226916306523
   PubMed Web of Science ®Google Scholar
• KasperMJaksVHohlDToftgardRBasal cell carcinoma – molecular biology and potential new therapiesJ Clin Invest2012122245546322293184
   PubMed Web of Science ®Google Scholar
• KaragasMRWeinstockMANelsonHHKeratinocyte carcinomas (basal and squamous cell carcinomas of the skin)SchottenfeldDFraumeniJFJrCancer Epidemiology and Prevention3rd edOxfordOxford University Press200612301250
   Google Scholar
• WeissGJKornRLMetastatic basal cell carcinoma in the era of Hedgehog signaling pathway inhibitorsCancer2012118215310531922511370
   PubMed Web of Science ®Google Scholar
• WallingHWFoskoSWGeraminejadPAWhitakerDCArpeyCJAggressive basal cell carcinoma: presentation, pathogenesis, and managementCancer Metastasis Rev2004233–438940215197337
   PubMed Web of Science ®Google Scholar
• LomasALeonardi-BeeJBath-HextallFA systematic review of worldwide incidence of nonmelanoma skin cancerBr J Dermatol201216651069108022251204
   PubMed Web of Science ®Google Scholar
• GuyGPEkwuemeDUYears of potential life lost and indirect costs of melanoma and non-melanoma skin cancer: a systematic review of the literaturePharmacoeconomics2011291086387421846158
   PubMed Web of Science ®Google Scholar
• WeinstockMAStillJMAssessing current treatment options for patients with severe/advanced basal cell carcinomaSemin Cutan Med Surg201130Suppl 4S10S1322177101
   PubMed Web of Science ®Google Scholar
• MarcilISternRSRisk of developing a subsequent nonmelanoma skin cancer in patients with a history of nonmelanoma skin cancer: a critical review of the literature and meta-analysisArch Dermatol2000136121524153011115165
   PubMedGoogle Scholar
• DesaiTChenCLDesaiAKirbyWBasic pharmacology of topical imiquimod, 5-fluorouracil, and diclofenac for the dermatologic surgeonDermatol Surg20123819710322092926
   PubMed Web of Science ®Google Scholar
• LeeSSelvaDHuilgolSCGoldbergRALeibovitchIPharmacological treatments for basal cell carcinomaDrugs200767691593417428108
   PubMed Web of Science ®Google Scholar
• TeglundSToftgardRHedgehog beyond medulloblastoma and basal cell carcinomaBiochim Biophys Acta20101805218120820085802
   PubMed Web of Science ®Google Scholar
• InghamPWNakanoYSegerCMechanisms and functions of Hedgehog signalling across the metazoaNat Rev Genet201112639340621502959
   PubMed Web of Science ®Google Scholar
• CaroILowJAThe role of the Hedgehog signaling pathway in the development of basal cell carcinoma and opportunities for treatmentClin Cancer Res201016133335333920439455
   PubMed Web of Science ®Google Scholar
• NgJMCurranTThe Hedgehog’s tale: developing strategies for targeting cancerNat Rev Cancer201111749350121614026
   PubMed Web of Science ®Google Scholar
• PoAFerrettiEMieleEHedgehog controls neural stem cells through p53-independent regulation of NanogEMBO J201029152646265820581804
   PubMed Web of Science ®Google Scholar
• TakebeNHarrisPJWarrenRQIvySPTargeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathwaysNat Rev Clin Oncol2011829710621151206
   PubMed Web of Science ®Google Scholar
• VarjosaloMTaipaleJHedgehog signalingJ Cell Sci2007120Pt 13617182898
   PubMed Web of Science ®Google Scholar
• InghamPWMcMahonAPHedgehog signaling in animal development: paradigms and principlesGenes Dev200115233059308711731473
   PubMed Web of Science ®Google Scholar
• BarakatMTHumkeEWScottMPLearning from Jekyll to control Hyde: Hedgehog signaling in development and cancerTrends Mol Med201016833734820696410
   PubMed Web of Science ®Google Scholar
• LumLBeachyPAThe Hedgehog response network: sensors, switches, and routersScience200430456781755175915205520
   PubMed Web of Science ®Google Scholar
• HooperJEScottMPCommunicating with HedgehogsNat Rev Mol Cell Biol20056430631715803137
   PubMed Web of Science ®Google Scholar
• InghamPWPlaczekMOrchestrating ontogenesis: variations on a theme by Sonic HedgehogNat Rev Genet200671184185017047684
   PubMed Web of Science ®Google Scholar
• TowersMTickleCGrowing models of vertebrate limb developmentDevelopment2009136217919019103802
   PubMed Web of Science ®Google Scholar
• MannRKBeachyPANovel lipid modifications of secreted protein signalsAnnu Rev Biochem20047389192315189162
   PubMed Web of Science ®Google Scholar
• TherondPPRelease and transportation of Hedgehog moleculesCurr Opin Cell Biol201224217318022366329
   PubMed Web of Science ®Google Scholar
• RohatgiRMilenkovicLScottMPPatched1 regulates Hedgehog signaling at the primary ciliumScience2007317583637237617641202
   PubMed Web of Science ®Google Scholar
• WollamJAntebiASterol regulation of metabolism, homeostasis, and developmentAnnu Rev Biochem20118088591621495846
   PubMed Web of Science ®Google Scholar
• CorcoranRBScottMPOxysterols stimulate Sonic Hedgehog signal transduction and proliferation of medulloblastoma cellsProc Natl Acad Sci U S A2006103228408841316707575
   PubMed Web of Science ®Google Scholar
• StruttHThomasCNakanoYMutations in the sterol-sensing domain of Patched suggest a role for vesicular trafficking in Smoothened regulationCurr Biol200111860861311369206
   PubMed Web of Science ®Google Scholar
• DwyerJRSeverNCarlsonMNelsonSFBeachyPAParhamiFOxysterols are novel activators of the Hedgehog signaling pathway in pluripotent mesenchymal cellsJ Biol Chem2007282128959896817200122
   PubMed Web of Science ®Google Scholar
• JohnsonJSMelitonVKimWKNovel oxysterols have pro-osteogenic and anti-adipogenic effects in vitro and induce spinal fusion in vivoJ Cell Biochem201111261673168421503957
   PubMed Web of Science ®Google Scholar
• SharpeHJde SauvageFJSignaling: an oxysterol ligand for SmoothenedNat Chem Biol20128213914022257852
   PubMed Web of Science ®Google Scholar
• NachtergaeleSMydockLKKrishnanKOxysterols are allosteric activators of the oncoprotein SmoothenedNat Chem Biol20128221122022231273
   PubMed Web of Science ®Google Scholar
• CanettieriGDi MarcotullioLGrecoAHistone deacetylase and Cullin3-REN(KCTD11) ubiquitin ligase interplay regulates Hedgehog signalling through Gli acetylationNat Cell Biol201012213214220081843
   PubMed Web of Science ®Google Scholar
• Pasca di MaglianoMHebrokMHedgehog signalling in cancer formation and maintenanceNat Rev Cancer200331290391114737121
   PubMed Web of Science ®Google Scholar
• GorlinRJNevoid basal-cell carcinoma syndromeMedicine (Baltimore)1987662981133547011
   PubMed Web of Science ®Google Scholar
• HahnHWickingCZaphiropoulousPGMutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndromeCell19968568418518681379
   PubMed Web of Science ®Google Scholar
• JohnsonRLRothmanALXieJHuman homolog of patched, a candidate gene for the basal cell nevus syndromeScience19962725268166816718658145
   PubMed Web of Science ®Google Scholar
• AszterbaumMRothmanAJohnsonRLIdentification of mutations in the human PATCHED gene in sporadic basal cell carcinomas and in patients with the basal cell nevus syndromeJ Invest Dermatol199811068858889620294
   PubMed Web of Science ®Google Scholar
• ReifenbergerJWolterMKnobbeCBSomatic mutations in the PTCH, SMOH, SUFUH and TP53 genes in sporadic basal cell carcinomasBr J Dermatol20051521435115656799
   PubMed Web of Science ®Google Scholar
• WolterMReifenbergerJSommerCMutations in the human homologue of the Drosophila segment polarity gene patched (PTCH) in sporadic basal cell carcinomas of the skin and primitive neuroectodermal tumors of the central nervous systemCancer Res19975713258125859205058
   PubMed Web of Science ®Google Scholar
• LamCWXieJToKFA frequent activated smoothened mutation in sporadic basal cell carcinomasOncogene19991838338369989836
   PubMed Web of Science ®Google Scholar
• XieJMuroneMLuohSMActivating Smoothened mutations in sporadic basal-cell carcinomaNature1998391666290929422511
   PubMed Web of Science ®Google Scholar
• ReifenbergerJWolterMWeberRGMissense mutations in SMOH in sporadic basal cell carcinomas of the skin and primitive neuroectodermal tumors of the central nervous systemCancer Res1998589179818039581815
   PubMed Web of Science ®Google Scholar
• OroAEHigginsKMHuZBonifasJMEpsteinEHJrScottMPBasal cell carcinomas in mice overexpressing Sonic HedgehogScience199727653138178219115210
   PubMed Web of Science ®Google Scholar
• KeelerRFTeratogenic compounds of Veratrum californicum (Durand) X. Cyclopia in rabbits produced by cyclopamineTeratology1970321751804986632
   PubMedGoogle Scholar
• IncardonaJPGaffieldWKapurRPRoelinkHThe teratogenic Veratrum alkaloid cyclopamine inhibits Sonic Hedgehog signal transductionDevelopment199812518355335629716521
   PubMed Web of Science ®Google Scholar
• TaipaleJChenJKCooperMKEffects of oncogenic mutations in Smoothened and Patched can be reversed by cyclopamineNature200040667991005100910984056
   PubMed Web of Science ®Google Scholar
• DahmaneNSanchezPGittonYThe Sonic Hedgehog–Gli pathway regulates dorsal brain growth and tumorigenesisDevelopment2001128245201521211748155
   PubMed Web of Science ®Google Scholar
• ChenJKTaipaleJCooperMKBeachyPAInhibition of Hedgehog signaling by direct binding of cyclopamine to SmoothenedGenes Dev200216212743274812414725
   PubMed Web of Science ®Google Scholar
• TabsSAvciOInduction of the differentiation and apoptosis of tumor cells in vivo with efficiency and selectivityEur J Dermatol20041429610215196999
   PubMed Web of Science ®Google Scholar
• De SmaeleEFerrettiEGulinoAVismodegib, a small-molecule inhibitor of the Hedgehog pathway for the treatment of advanced cancersCurr Opin Investig Drugs2010116707718
   PubMedGoogle Scholar
• DlugoszAAgrawalSKirkpatrickPVismodegibNat Rev Drug Discov201211643743822653209
   PubMed Web of Science ®Google Scholar
• RobargeKDBruntonSACastanedoGMGDC-0449 – a potent inhibitor of the Hedgehog pathwayBioorg Med Chem Lett200919195576558119716296
   PubMed Web of Science ®Google Scholar
• Von HoffDDLoRussoPMRudinCMInhibition of the Hedgehog pathway in advanced basal-cell carcinomaN Engl J Med2009361121164117219726763
   PubMed Web of Science ®Google Scholar
• SekulicAMigdenMROroAEEfficacy and safety of vismodegib in advanced basal-cell carcinomaN Engl J Med2012366232171217922670903
   PubMed Web of Science ®Google Scholar
• US Food and Drug AdministrationFDA labeling information: Erivedge2012 Available from: http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203388lbl.pdfAccessed November 5, 2012
   Google Scholar
• TangJYMackay-WigganJMAszterbaumMInhibiting the Hedgehog pathway in patients with the basal-cell nevus syndromeN Engl J Med2012366232180218822670904
   PubMed Web of Science ®Google Scholar
• RudinCMHannCLLaterraJTreatment of medulloblastoma with Hedgehog pathway inhibitor GDC-0449N Engl J Med2009361121173117819726761
   PubMed Web of Science ®Google Scholar
• YauchRLDijkgraafGJAlickeBSmoothened mutation confers resistance to a Hedgehog pathway inhibitor in medulloblastomaScience2009326595257257419726788
   PubMed Web of Science ®Google Scholar
• WilliamsJAGuicheritOMZaharianBIIdentification of a small molecule inhibitor of the Hedgehog signaling pathway: effects on basal cell carcinoma-like lesionsProc Natl Acad Sci U S A200310084616462112679522
   PubMed Web of Science ®Google Scholar
• Frank-KamenetskyMZhangXMBottegaSSmall-molecule modulators of Hedgehog signaling: identification and characterization of Smoothened agonists and antagonistsJ Biol2002121012437772
   PubMedGoogle Scholar
• BuonamiciSWilliamsJMorrisseyMInterfering with resistance to smoothened antagonists by inhibition of the PI3K pathway in medulloblastomaSci Transl Med201025151ra70
   PubMed Web of Science ®Google Scholar
• SkvaraHKalthoffFMeingassnerJGTopical treatment of basal cell carcinomas in nevoid basal cell carcinoma syndrome with a smoothened inhibitorJ Invest Dermatol201113181735174421430703
   PubMed Web of Science ®Google Scholar
• NovartisInnovation Updates: Key Developments in the Fourth Quarter of 2011BaselNovartis2012 Available from: http://www.novartis.com/downloads/investors/financial-results/q4-2011-innovation-tables.pdfAccessed November 5, 2012
   Google Scholar
• ParkKSMartelottoLGPeiferMA crucial requirement for Hedgehog signaling in small cell lung cancerNat Med201117111504150821983857
   PubMed Web of Science ®Google Scholar
• TangJYMarghoobAAEmerging treatments and signaling pathway inhibitorsSemin Cutan Med Surg201130Suppl 4S14S1822177102
   PubMed Web of Science ®Google Scholar
• LappanoRMaggioliniMG protein-coupled receptors: novel targets for drug discovery in cancerNat Rev Drug Discov2011101476021193867
   PubMed Web of Science ®Google Scholar
• TremblayMRNeslerMWeatherheadRCastroACRecent patents for Hedgehog pathway inhibitors for the treatment of malignancyExpert Opin Ther Pat20091981039105619505195
   PubMed Web of Science ®Google Scholar
• TremblayMRLescarbeauAGroganMJDiscovery of a potent and orally active Hedgehog pathway antagonist (IPI-926)J Med Chem200952144400441819522463
   PubMed Web of Science ®Google Scholar
• TremblayMRMcGovernKReadMACastroACNew developments in the discovery of small molecule Hedgehog pathway antagonistsCurr Opin Chem Biol201014342843520399136
   PubMed Web of Science ®Google Scholar
• LeeMJHattonBAVillavicencioEHHedgehog pathway inhibitor saridegib (IPI-926) increases lifespan in a mouse medulloblastoma modelProc Natl Acad Sci U S A2012109207859786422550175
   PubMed Web of Science ®Google Scholar
• DeanMRzhetskyAAllikmetsRThe human ATP-binding cassette (ABC) transporter superfamilyGenome Res20011171156116611435397
   PubMed Web of Science ®Google Scholar
• LauthMBergstromAShimokawaTToftgardRInhibition of GLI-mediated transcription and tumor cell growth by small-molecule antagonistsProc Natl Acad Sci U S A2007104208455846017494766
   PubMed Web of Science ®Google Scholar
• RobeyRWMasseyPRAmiri-KordestaniLBatesSEABC transporters: unvalidated therapeutic targets in cancer and the CNSAnticancer Agents Med Chem201010862563321189132
   PubMed Web of Science ®Google Scholar
• ZhangYLaterraJPomperMGHedgehog pathway inhibitor HhAntag691 is a potent inhibitor of ABCG2/BCRP and ABCB1/PgpNeoplasia20091119610119107236
   PubMed Web of Science ®Google Scholar
• WongHChenJZChouBPreclinical assessment of the absorption, distribution, metabolism and excretion of GDC-0449 (2-chloro-N-(4-chloro-3-(pyridin-2-yl)phenyl)-4-(methylsulfonyl) benzamide), an orally bioavailable systemic Hedgehog signalling pathway inhibitorXenobiotica2009391185086119845436
   PubMed Web of Science ®Google Scholar
• RudinCMWeissGJChangAA phase 1 study of IPI-926, an inhibitor of the Hedgehog pathway, in patients with advanced or metastatic solid tumors [abstract]Ann Oncol201021Suppl 8viii164
   Google Scholar
• MunchhofMJLiQShavnyaADiscovery of PF-04449913, a potent and orally bioavailable inhibitor of SmoothenedACS Med Chem Lett20123210611124900436
   PubMed Web of Science ®Google Scholar
• JamiesonCCortesJEOehlerVPhase 1 dose-escalation study of PF-04449913, an oral Hedgehog (Hh) inhibitor, in patients with select hematologic malignancies [abstract]Blood2011118424
   Web of Science ®Google Scholar
• PapayannidisCGuadagnuoloVIacobucciIPF-04449913 reverts multi drug resistance (MDR) by a strong down-regulation of ABCA2 and BCL2 on leukemia stem cells in phase I acute myeloid leukemia and chronic myeloid leukemia treated patients [abstract]Cancer Res2012728 Suppl 14619
   Web of Science ®Google Scholar
• DijkgraafGJAlickeBWeinmannLSmall molecule inhibition of GDC-0449 refractory smoothened mutants and downstream mechanisms of drug resistanceCancer Res201171243544421123452
   PubMed Web of Science ®Google Scholar
• YangBHirdAWRussellDJDiscovery of novel Hedgehog antagonists from cell-based screening: isosteric modification of p38 bisamides as potent inhibitors of SMOBioorg Med Chem Lett201222144907491122704236
   PubMed Web of Science ®Google Scholar
• KimJTangJYGongRItraconazole, a commonly used anti-fungal that inhibits Hedgehog pathway activity and cancer growthCancer Cell201017438839920385363
   PubMed Web of Science ®Google Scholar
• KimDKimJSpaunhurstKAn open-label, exploratory phase II study of oral itraconazole for the treatment of basal cell carcinoma [abstract]Cancer Res201272Suppl 8LB-223
   Web of Science ®Google Scholar
• NacevBAGrassiPDellAHaslamSMLiuJOThe antifungal drug itraconazole inhibits vascular endothelial growth factor receptor 2 (VEGFR2) glycosylation, trafficking, and signaling in endothelial cellsJ Biol Chem201128651440454405622025615
   PubMed Web of Science ®Google Scholar
• ShiWNacevBAAftabBTHeadSRudinCMLiuJOItraconazole side chain analogues: structure–activity relationship studies for inhibition of endothelial cell proliferation, vascular endothelial growth factor receptor 2 (VEGFR2) glycosylation, and Hedgehog signalingJ Med Chem201154207363737421936514
   PubMed Web of Science ®Google Scholar
• BruntonSAStibbardJHRubinLLPotent inhibitors of the Hedgehog signaling pathwayJ Med Chem20085151108111018275133
   PubMed Web of Science ®Google Scholar
• DeebKKTrumpDLJohnsonCSVitamin D signalling pathways in cancer: potential for anticancer therapeuticsNat Rev Cancer20077968470017721433
   PubMed Web of Science ®Google Scholar
• BikleDDVitamin D and the skin: physiology and pathophysiologyRev Endocr Metab Disord201213131921845365
   PubMed Web of Science ®Google Scholar
• BijlsmaMFSpekCAZivkovicDvan de WaterSRezaeeFPeppelenboschMPRepression of smoothened by patched-dependent (pro-)vitamin D3 secretionPLoS Biol200648e23216895439
   PubMed Web of Science ®Google Scholar
• TangJYXiaoTZOdaYVitamin D3 inhibits Hedgehog signaling and proliferation in murine basal cell carcinomasCancer Prev Res (Phila)20114574475121436386
   PubMed Web of Science ®Google Scholar
• TeichertAEElaliehHEliasPMWelshJBikleDDOverexpression of Hedgehog signaling is associated with epidermal tumor formation in vitamin D receptor-null miceJ Invest Dermatol2011131112289229721814234
   PubMed Web of Science ®Google Scholar
• KamradtJRafiLMitscheleTAnalysis of the vitamin D system in cutaneous malignanciesRecent Results Cancer Res200316425926912899528
   PubMedGoogle Scholar
• UhmannANiemannHLammeringBAntitumoral effects of calcitriol in basal cell carcinomas involve inhibition of Hedgehog signaling and induction of vitamin D receptor signaling and differentiationMol Cancer Ther201110112179218821878656
   PubMed Web of Science ®Google Scholar
• DeberardinisAMBanerjeeUMillerMLemieuxSHaddenMKProbing the structural requirements for vitamin D3 inhibition of the Hedgehog signaling pathwayBioorg Med Chem Lett201222144859486322687748
   PubMed Web of Science ®Google Scholar
• StantonBZPengLFMaloofNA small molecule that binds Hedgehog and blocks its signaling in human cellsNat Chem Biol20095315415619151731
   PubMed Web of Science ®Google Scholar
• PengLFStantonBZMaloofNWangXSchreiberSLSyntheses of aminoalcohol-derived macrocycles leading to a small-molecule binder to and inhibitor of Sonic HedgehogBioorg Med Chem Lett2009196319632519819139
   PubMed Web of Science ®Google Scholar
• DockendorffCNagiecMMWeiwerMMacrocyclic Hedgehog pathway inhibitors: optimization of cellular activity and mode of action studiesACS Med Chem Lett201231080881323074541
   PubMed Web of Science ®Google Scholar
• EricsonJMortonSKawakamiARoelinkHJessellTMTwo critical periods of Sonic Hedgehog signaling required for the specification of motor neuron identityCell19968746616738929535
   PubMed Web of Science ®Google Scholar
• PepinskyRBRayhornPDayESMapping Sonic Hedgehog-receptor interactions by steric interferenceJ Biol Chem200027515109951100110753901
   PubMed Web of Science ®Google Scholar
• HymanJMFirestoneAJHeineVMSmall-molecule inhibitors reveal multiple strategies for Hedgehog pathway blockadeProc Natl Acad Sci U S A200910633141321413719666565
   PubMed Web of Science ®Google Scholar
• ChennaVHuCPramanikDA polymeric nanoparticle encapsulated small-molecule inhibitor of Hedgehog signaling (NanoHHI) bypasses secondary mutational resistance to Smoothened antagonistsMol Cancer Ther201211116517322027695
   PubMed Web of Science ®Google Scholar
• XuYChennaVHuCPolymeric nanoparticle-encapsulated Hedgehog pathway inhibitor HPI-1 (NanoHHI) inhibits systemic metastases in an orthotopic model of human hepatocellular carcinomaClin Cancer Res20121851291130221868763
   PubMed Web of Science ®Google Scholar
• PanDLiYLiZWangYWangPLiangYGli inhibitor GANT61 causes apoptosis in myeloid leukemia cells and acts in synergy with rapamycinLeuk Res201236674274822398221
   PubMed Web of Science ®Google Scholar
• De SmaeleEDi MarcotullioLMorettiMIdentification and characterization of KCASH2 and KCASH3, 2 novel Cullin3 adaptors suppressing histone deacetylase and Hedgehog activity in medulloblastomaNeoplasia201113437438521472142
   PubMed Web of Science ®Google Scholar
• Gutierrez-MazariegosJTheodosiouMCampo-PaysaaFSchubertMVitamin A: a multifunctional tool for developmentSemin Cell Dev Biol201122660361021693195
   PubMed Web of Science ®Google Scholar
• GudasLJEmerging roles for retinoids in regeneration and differentiation in normal and disease statesBiochim Biophys Acta20121821121322121855651
   PubMed Web of Science ®Google Scholar
• TangXHGudasLJRetinoids, retinoic acid receptors, and cancerAnnu Rev Pathol2011634536421073338
   PubMed Web of Science ®Google Scholar
• HansenLASigmanCCAndreolaFRossSAKelloffGJDe LucaLMRetinoids in chemoprevention and differentiation therapyCarcinogenesis20002171271127910874003
   PubMed Web of Science ®Google Scholar
• AltucciLLeibowitzMDOgilvieKMde LaraARGronemeyerHRAR and RXR modulation in cancer and metabolic diseaseNat Rev Drug Discov200761079381017906642
   PubMed Web of Science ®Google Scholar
• IngvesCJemecGBCombined imiquimod and acitretin for nonsurgical treatment of basal cell carcinomaScand J Plast Reconstr Surg Hand Surg200337529329514649688
   PubMed Web of Science ®Google Scholar
• LienMHFenskeNAGlassLFAdvances in the chemoprevention of non-melanoma skin cancer in high-risk organ transplant recipientsSemin Oncol201239213413822484184
   PubMed Web of Science ®Google Scholar
• WeinstockMABinghamSFDigiovannaJJTretinoin and the prevention of keratinocyte carcinoma (basal and squamous cell carcinoma of the skin): a Veterans Affairs randomized chemoprevention trialJ Invest Dermatol201213261583159022318383
   PubMed Web of Science ®Google Scholar
• ChandraratnaRATazarotene – first of a new generation of receptor-selective retinoidsBr J Dermatol1996135Suppl 4918259035701
   PubMed Web of Science ®Google Scholar
• BianchiLOrlandiACampioneETopical treatment of basal cell carcinoma with tazarotene: a clinicopathological study on a large series of casesBr J Dermatol2004151114815615270884
   PubMed Web of Science ®Google Scholar
• OrlandiABianchiLCostanzoACampioneEGiusto SpagnoliLChimentiSEvidence of increased apoptosis and reduced proliferation in basal cell carcinomas treated with tazaroteneJ Invest Dermatol200412241037104115102095
   PubMed Web of Science ®Google Scholar
• JonesPHBurnettRDFainaruIA phase 1 study of tazarotene in adults with advanced cancerBr J Cancer200389580881512942109
   PubMed Web of Science ®Google Scholar
• SoPLLeeKHebertJTopical tazarotene chemoprevention reduces basal cell carcinoma number and size in Ptch1+/− mice exposed to ultraviolet or ionizing radiationCancer Res200464134385438915231643
   PubMed Web of Science ®Google Scholar
• GoyettePAllanDPeschardPChenCFWangWLohnesDRegulation of Gli activity by all-trans retinoic acid in mouse keratinocytesCancer Res200060195386538911034076
   PubMed Web of Science ®Google Scholar
• MetcalfeCde SauvageFJHedgehog fights back: mechanisms of acquired resistance against Smoothened antagonistsCancer Res201171155057506121771911
   PubMed Web of Science ®Google Scholar
• KasperMSchnidarHNeillGWSelective modulation of Hedgehog/GLI target gene expression by epidermal growth factor signaling in human keratinocytesMol Cell Biol200626166283629816880536
   PubMed Web of Science ®Google Scholar
• EberlMKlingerSMangelbergerDHedgehog-EGFR cooperation response genes determine the oncogenic phenotype of basal cell carcinoma and tumour-initiating pancreatic cancer cellEMBO Mol Med20124321823322294553
   PubMed Web of Science ®Google Scholar
• SellheyerKBasal cell carcinoma: cell of origin, cancer stem cell hypothesis and stem cell markersBr J Dermatol2011164469671121128907
   PubMed Web of Science ®Google Scholar
• MerchantAAMatsuiWTargeting Hedgehog – a cancer stem cell pathwayClin Cancer Res201016123130314020530699
   PubMed Web of Science ®Google Scholar